Answers are grounded in this paper and cite their sources.
The title compounds, [(1R,1'R,2R,2'R)-2,2'-bis(diphenylphosphanyl)-1,1'-dicyclopentane](η(4)-norbornadiene)rhodium(I) tetrafluoridoborate, [Rh(C34H36P2)(C7H8)]BF4, (I), and [(1R,1'R,2R,2'R)-2,2'-bis(diphenylphosphanyl)-1,1'-dicyclopentane][η(4)-(Z,Z)-cycloocta-1,5-diene]rhodium(I) tetrafluoridoborate dichloromethane monosolvate, [Rh(C34H36P2)(C8H12)]BF4·CH2Cl2, (II), are applied as precatalysts in asymmetric homogeneous hydrogenation, e.g. in the reduction of dehydroamino acids, affording excellent enantiomeric excesses [Zhu, Cao, Jiang & Zhang (1997). J. Am. Chem. Soc. 119, 1799-1800].
No takes yet. Share an insight, caveat, or question.
Meißner et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: